Pivotal Bio Venture Partners Investment Advisor LLC Arcutis Biotherapeutics, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $111 Million
- Q2 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 2,041,108 shares of ARQT stock, worth $17 Million. This represents 17.1% of its overall portfolio holdings.
Number of Shares
2,041,108
Previous 2,028,008
0.65%
Holding current value
$17 Million
Previous $20.1 Million
5.55%
% of portfolio
17.1%
Previous 14.74%
Shares
6 transactions
Others Institutions Holding ARQT
# of Institutions
193Shares Held
128MCall Options Held
5.43MPut Options Held
257K-
Jennison Associates LLC11.6MShares$96.2 Million0.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY10MShares$83.1 Million3.89% of portfolio
-
Rubric Capital Management LP New York, NY9.82MShares$81.6 Million2.7% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$73 Million4.82% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$71.7 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $500M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...